Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Stereotactic-guided Biopsy Instrument Market Research Report 2020

  • BMR3958936
  • 123 Pages
  • August 2020
  • Medical Devices
Download Sample    Get Discount   
 
The global Stereotactic-guided Biopsy Instrument market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

This report focuses on Stereotactic-guided Biopsy Instrument volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Stereotactic-guided Biopsy Instrument market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Stereotactic-guided Biopsy Instrument Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global Stereotactic-guided Biopsy Instrument Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China and Japan. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Stereotactic-guided Biopsy Instrument Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

Following are the segments covered by the report are:

Needle-based Biopsy Instruments

Localization Wires

Procedure Trays

Others

By Application:

Breast Biopsy

Lung Biopsy

Colorectal Biopsy

Prostate Biopsy

Others

Key Players:

The Key manufacturers that are operating in the global Stereotactic-guided Biopsy Instrument market are:

C. R. Bard, Inc. (U.S.)

Becton, Dickinson and Company (U.S.)

Cook Group Incorporated (U.S.)

Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

Argon Medical Devices (U.S.)

B. Braun Melsungen AG (Germany)

Cardinal Health, Inc. (U.S.)

Olympus Corporation (Japan)

Boston Scientific Corporation (U.S.)

FUJIFILM Holdings Corporation (Japan)

INRAD, Inc. (U.S.)

Medtronic plc (Ireland)

Competitive Landscape

The analysts have provided a comprehensive analysis of the competitive landscape of the global Stereotactic-guided Biopsy Instrument market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

1 Stereotactic-guided Biopsy Instrument Market Overview

1.1 Product Overview and Scope of Stereotactic-guided Biopsy Instrument

1.2 Stereotactic-guided Biopsy Instrument Segment by Type

1.2.1 Global Stereotactic-guided Biopsy Instrument Production Growth Rate Comparison by Type 2020 VS 2026

1.2.2 Needle-based Biopsy Instruments

1.2.3 Localization Wires

1.2.4 Procedure Trays

1.2.5 Others

1.3 Stereotactic-guided Biopsy Instrument Segment by Application

1.3.1 Stereotactic-guided Biopsy Instrument Consumption Comparison by Application: 2020 VS 2026

1.3.2 Breast Biopsy

1.3.3 Lung Biopsy

1.3.4 Colorectal Biopsy

1.3.5 Prostate Biopsy

1.3.6 Others

1.4 Global Stereotactic-guided Biopsy Instrument Market by Region

1.4.1 Global Stereotactic-guided Biopsy Instrument Market Size Estimates and Forecasts by Region: 2020 VS 2026

1.4.2 North America Estimates and Forecasts (2015-2026)

1.4.3 Europe Estimates and Forecasts (2015-2026)

1.4.4 China Estimates and Forecasts (2015-2026)

1.4.5 Japan Estimates and Forecasts (2015-2026)

1.5 Global Stereotactic-guided Biopsy Instrument Growth Prospects

1.5.1 Global Stereotactic-guided Biopsy Instrument Revenue Estimates and Forecasts (2015-2026)

1.5.2 Global Stereotactic-guided Biopsy Instrument Production Capacity Estimates and Forecasts (2015-2026)

1.5.3 Global Stereotactic-guided Biopsy Instrument Production Estimates and Forecasts (2015-2026)

1.6 Stereotactic-guided Biopsy Instrument Industry

1.7 Stereotactic-guided Biopsy Instrument Market Trends

2 Market Competition by Manufacturers

2.1 Global Stereotactic-guided Biopsy Instrument Production Capacity Market Share by Manufacturers (2015-2020)

2.2 Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2015-2020)

2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.4 Global Stereotactic-guided Biopsy Instrument Average Price by Manufacturers (2015-2020)

2.5 Manufacturers Stereotactic-guided Biopsy Instrument Production Sites, Area Served, Product Types

2.6 Stereotactic-guided Biopsy Instrument Market Competitive Situation and Trends

2.6.1 Stereotactic-guided Biopsy Instrument Market Concentration Rate

2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue

2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

3.1 Global Production Capacity of Stereotactic-guided Biopsy Instrument Market Share by Regions (2015-2020)

3.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions (2015-2020)

3.3 Global Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.4 North America Stereotactic-guided Biopsy Instrument Production

3.4.1 North America Stereotactic-guided Biopsy Instrument Production Growth Rate (2015-2020)

3.4.2 North America Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.5 Europe Stereotactic-guided Biopsy Instrument Production

3.5.1 Europe Stereotactic-guided Biopsy Instrument Production Growth Rate (2015-2020)

3.5.2 Europe Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.6 China Stereotactic-guided Biopsy Instrument Production

3.6.1 China Stereotactic-guided Biopsy Instrument Production Growth Rate (2015-2020)

3.6.2 China Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.7 Japan Stereotactic-guided Biopsy Instrument Production

3.7.1 Japan Stereotactic-guided Biopsy Instrument Production Growth Rate (2015-2020)

3.7.2 Japan Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Stereotactic-guided Biopsy Instrument Consumption by Regions

4.1 Global Stereotactic-guided Biopsy Instrument Consumption by Regions

4.1.1 Global Stereotactic-guided Biopsy Instrument Consumption by Region

4.1.2 Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Region

4.2 North America

4.2.1 North America Stereotactic-guided Biopsy Instrument Consumption by Countries

4.2.2 U.S.

4.2.3 Canada

4.3 Europe

4.3.1 Europe Stereotactic-guided Biopsy Instrument Consumption by Countries

4.3.2 Germany

4.3.3 France

4.3.4 U.K.

4.3.5 Italy

4.3.6 Russia

4.4 Asia Pacific

4.4.1 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Region

4.4.2 China

4.4.3 Japan

4.4.4 South Korea

4.4.5 Taiwan

4.4.6 Southeast Asia

4.4.7 India

4.4.8 Australia

4.5 Latin America

4.5.1 Latin America Stereotactic-guided Biopsy Instrument Consumption by Countries

4.5.2 Mexico

4.5.3 Brazil

5 Stereotactic-guided Biopsy Instrument Production, Revenue, Price Trend by Type

5.1 Global Stereotactic-guided Biopsy Instrument Production Market Share by Type (2015-2020)

5.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2015-2020)

5.3 Global Stereotactic-guided Biopsy Instrument Price by Type (2015-2020)

5.4 Global Stereotactic-guided Biopsy Instrument Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Stereotactic-guided Biopsy Instrument Market Analysis by Application

6.1 Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application (2015-2020)

6.2 Global Stereotactic-guided Biopsy Instrument Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Stereotactic-guided Biopsy Instrument Business

7.1 C. R. Bard, Inc. (U.S.)

7.1.1 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.1.2 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.1.4 C. R. Bard, Inc. (U.S.) Main Business and Markets Served

7.2 Becton, Dickinson and Company (U.S.)

7.2.1 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.2.2 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.2.4 Becton, Dickinson and Company (U.S.) Main Business and Markets Served

7.3 Cook Group Incorporated (U.S.)

7.3.1 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.3.2 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.3.4 Cook Group Incorporated (U.S.) Main Business and Markets Served

7.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

7.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Main Business and Markets Served

7.5 Argon Medical Devices (U.S.)

7.5.1 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.5.2 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.5.4 Argon Medical Devices (U.S.) Main Business and Markets Served

7.6 B. Braun Melsungen AG (Germany)

7.6.1 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.6.2 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.6.4 B. Braun Melsungen AG (Germany) Main Business and Markets Served

7.7 Cardinal Health, Inc. (U.S.)

7.7.1 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.7.2 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.7.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.7.4 Cardinal Health, Inc. (U.S.) Main Business and Markets Served

7.8 Olympus Corporation (Japan)

7.8.1 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.8.2 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.8.4 Olympus Corporation (Japan) Main Business and Markets Served

7.9 Boston Scientific Corporation (U.S.)

7.9.1 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.9.2 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.9.4 Boston Scientific Corporation (U.S.) Main Business and Markets Served

7.10 FUJIFILM Holdings Corporation (Japan)

7.10.1 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.10.2 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.10.4 FUJIFILM Holdings Corporation (Japan) Main Business and Markets Served

7.11 INRAD, Inc. (U.S.)

7.11.1 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.11.2 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.11.3 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.11.4 INRAD, Inc. (U.S.) Main Business and Markets Served

7.12 Medtronic plc (Ireland)

7.12.1 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

7.12.2 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product Introduction, Application and Specification

7.12.3 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.12.4 Medtronic plc (Ireland) Main Business and Markets Served

8 Stereotactic-guided Biopsy Instrument Manufacturing Cost Analysis

8.1 Stereotactic-guided Biopsy Instrument Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Raw Materials Price Trend

8.1.3 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument

8.4 Stereotactic-guided Biopsy Instrument Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Stereotactic-guided Biopsy Instrument Distributors List

9.3 Stereotactic-guided Biopsy Instrument Customers

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities and Drivers

10.3 Challenges

10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

11.1 Global Forecasted Production of Stereotactic-guided Biopsy Instrument (2021-2026)

11.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument (2021-2026)

11.3 Global Forecasted Price of Stereotactic-guided Biopsy Instrument (2021-2026)

11.4 Global Stereotactic-guided Biopsy Instrument Production Forecast by Regions (2021-2026)

11.4.1 North America Stereotactic-guided Biopsy Instrument Production, Revenue Forecast (2021-2026)

11.4.2 Europe Stereotactic-guided Biopsy Instrument Production, Revenue Forecast (2021-2026)

11.4.3 China Stereotactic-guided Biopsy Instrument Production, Revenue Forecast (2021-2026)

11.4.4 Japan Stereotactic-guided Biopsy Instrument Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

12.1 Global Forecasted and Consumption Demand Analysis of Stereotactic-guided Biopsy Instrument

12.2 North America Forecasted Consumption of Stereotactic-guided Biopsy Instrument by Country

12.3 Europe Market Forecasted Consumption of Stereotactic-guided Biopsy Instrument by Country

12.4 Asia Pacific Market Forecasted Consumption of Stereotactic-guided Biopsy Instrument by Regions

12.5 Latin America Forecasted Consumption of Stereotactic-guided Biopsy Instrument

13 Forecast by Type and by Application (2021-2026)

13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)

13.1.1 Global Forecasted Production of Stereotactic-guided Biopsy Instrument by Type (2021-2026)

13.1.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Type (2021-2026)

13.1.2 Global Forecasted Price of Stereotactic-guided Biopsy Instrument by Type (2021-2026)

13.2 Global Forecasted Consumption of Stereotactic-guided Biopsy Instrument by Application (2021-2026)

14 Research Finding and Conclusion

15 Methodology and Data Source

15.1 Methodology/Research Approach

15.1.1 Research Programs/Design

15.1.2 Market Size Estimation

15.1.3 Market Breakdown and Data Triangulation

15.2 Data Source

15.2.1 Secondary Sources

15.2.2 Primary Sources

15.3 Author List

15.4 Disclaimer

List of Tables

Table 1. Global Stereotactic-guided Biopsy Instrument Production (K Units) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Stereotactic-guided Biopsy Instrument Market Size by Type (K Units) (US$ Million) (2020 VS 2026)

Table 3. Global Stereotactic-guided Biopsy Instrument Consumption (K Units) Comparison by Application: 2020 VS 2026

Table 4. Global Stereotactic-guided Biopsy Instrument Production (K Units) by Manufacturers

Table 5. Global Stereotactic-guided Biopsy Instrument Production (K Units) by Manufacturers (2015-2020)

Table 6. Global Stereotactic-guided Biopsy Instrument Production Share by Manufacturers (2015-2020)

Table 7. Global Stereotactic-guided Biopsy Instrument Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2015-2020)

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stereotactic-guided Biopsy Instrument as of 2019)

Table 10. Global Market Stereotactic-guided Biopsy Instrument Average Price (USD/Unit) of Key Manufacturers (2015-2020)

Table 11. Manufacturers Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 12. Manufacturers Stereotactic-guided Biopsy Instrument Product Types

Table 13. Global Stereotactic-guided Biopsy Instrument Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Stereotactic-guided Biopsy Instrument Capacity (K Units) by Region (2015-2020)

Table 16. Global Stereotactic-guided Biopsy Instrument Production (K Units) by Region (2015-2020)

Table 17. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) by Region (2015-2020)

Table 18. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2015-2020)

Table 19. Global Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 20. North America Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 21. Europe Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 22. China Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 23. Japan Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 24. Global Stereotactic-guided Biopsy Instrument Consumption (K Units) Market by Region (2015-2020)

Table 25. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Region (2015-2020)

Table 26. North America Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)

Table 27. Europe Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)

Table 28. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)

Table 29. Latin America Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)

Table 30. Global Stereotactic-guided Biopsy Instrument Production (K Units) by Type (2015-2020)

Table 31. Global Stereotactic-guided Biopsy Instrument Production Share by Type (2015-2020)

Table 32. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) by Type (2015-2020)

Table 33. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2015-2020)

Table 34. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Type (2015-2020)

Table 35. Global Stereotactic-guided Biopsy Instrument Consumption (K Units) by Application (2015-2020)

Table 36. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application (2015-2020)

Table 37. Global Stereotactic-guided Biopsy Instrument Consumption Growth Rate by Application (2015-2020)

Table 38. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 39. C. R. Bard, Inc. (U.S.) Production Sites and Area Served

Table 40. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 41. C. R. Bard, Inc. (U.S.) Main Business and Markets Served

Table 42. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 43. Becton, Dickinson and Company (U.S.) Production Sites and Area Served

Table 44. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 45. Becton, Dickinson and Company (U.S.) Main Business and Markets Served

Table 46. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 47. Cook Group Incorporated (U.S.) Production Sites and Area Served

Table 48. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 49. Cook Group Incorporated (U.S.) Main Business and Markets Served

Table 50. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 51. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Production Sites and Area Served

Table 52. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 53. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Main Business and Markets Served

Table 54. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 55. Argon Medical Devices (U.S.) Production Sites and Area Served

Table 56. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 57. Argon Medical Devices (U.S.) Main Business and Markets Served

Table 58. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 59. B. Braun Melsungen AG (Germany) Production Sites and Area Served

Table 60. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 61. B. Braun Melsungen AG (Germany) Main Business and Markets Served

Table 62. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 63. Cardinal Health, Inc. (U.S.) Production Sites and Area Served

Table 64. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 65. Cardinal Health, Inc. (U.S.) Main Business and Markets Served

Table 66. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 67. Olympus Corporation (Japan) Production Sites and Area Served

Table 68. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 69. Olympus Corporation (Japan) Main Business and Markets Served

Table 70. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 71. Boston Scientific Corporation (U.S.) Production Sites and Area Served

Table 72. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 73. Boston Scientific Corporation (U.S.) Main Business and Markets Served

Table 74. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 75. FUJIFILM Holdings Corporation (Japan) Production Sites and Area Served

Table 76. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. FUJIFILM Holdings Corporation (Japan) Main Business and Markets Served

Table 78. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 79. INRAD, Inc. (U.S.) Production Sites and Area Served

Table 80. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. INRAD, Inc. (U.S.) Main Business and Markets Served

Table 82. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Production Sites and Area Served

Table 83. Medtronic plc (Ireland) Production Sites and Area Served

Table 84. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 85. Medtronic plc (Ireland) Main Business and Markets Served

Table 86. Production Base and Market Concentration Rate of Raw Material

Table 87. Key Suppliers of Raw Materials

Table 88. Stereotactic-guided Biopsy Instrument Distributors List

Table 89. Stereotactic-guided Biopsy Instrument Customers List

Table 90. Market Key Trends

Table 91. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 92. Key Challenges

Table 93. Global Stereotactic-guided Biopsy Instrument Production (K Units) Forecast by Region (2021-2026)

Table 94. North America Stereotactic-guided Biopsy Instrument Consumption Forecast 2021-2026 (K Units) by Country

Table 95. Europe Stereotactic-guided Biopsy Instrument Consumption Forecast 2021-2026 (K Units) by Country

Table 96. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Forecast 2021-2026 (K Units) by Regions

Table 97. Latin America Stereotactic-guided Biopsy Instrument Consumption Forecast 2021-2026 (K Units) by Country

Table 98. Global Stereotactic-guided Biopsy Instrument Consumption (K Units) Forecast by Regions (2021-2026)

Table 99. Global Stereotactic-guided Biopsy Instrument Production (K Units) Forecast by Type (2021-2026)

Table 100. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) Forecast by Type (2021-2026)

Table 101. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) Forecast by Type (2021-2026)

Table 102. Global Stereotactic-guided Biopsy Instrument Consumption (K Units) Forecast by Application (2021-2026)

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Stereotactic-guided Biopsy Instrument

Figure 2. Global Stereotactic-guided Biopsy Instrument Production Market Share by Type: 2020 VS 2026

Figure 3. Needle-based Biopsy Instruments Product Picture

Figure 4. Localization Wires Product Picture

Figure 5. Procedure Trays Product Picture

Figure 6. Others Product Picture

Figure 7. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application: 2020 VS 2026

Figure 8. Breast Biopsy

Figure 9. Lung Biopsy

Figure 10. Colorectal Biopsy

Figure 11. Prostate Biopsy

Figure 12. Others

Figure 13. North America Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate (2015-2026)

Figure 14. Europe Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate (2015-2026)

Figure 15. China Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate (2015-2026)

Figure 16. Japan Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate (2015-2026)

Figure 17. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) (2015-2026)

Figure 18. Global Stereotactic-guided Biopsy Instrument Production Capacity (K Units) (2015-2026)

Figure 19. Stereotactic-guided Biopsy Instrument Production Share by Manufacturers in 2019

Figure 20. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers in 2019

Figure 21. Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Market Stereotactic-guided Biopsy Instrument Average Price (USD/Unit) of Key Manufacturers in 2019

Figure 23. The Global 5 and 10 Largest Players: Market Share by Stereotactic-guided Biopsy Instrument Revenue in 2019

Figure 24. Global Stereotactic-guided Biopsy Instrument Production Market Share by Region (2015-2020)

Figure 25. Global Stereotactic-guided Biopsy Instrument Production Market Share by Region in 2019

Figure 26. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2015-2020)

Figure 27. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region in 2019

Figure 28. Global Stereotactic-guided Biopsy Instrument Production (K Units) Growth Rate (2015-2020)

Figure 29. North America Stereotactic-guided Biopsy Instrument Production (K Units) Growth Rate (2015-2020)

Figure 30. Europe Stereotactic-guided Biopsy Instrument Production (K Units) Growth Rate (2015-2020)

Figure 31. China Stereotactic-guided Biopsy Instrument Production (K Units) Growth Rate (2015-2020)

Figure 32. Japan Stereotactic-guided Biopsy Instrument Production (K Units) Growth Rate (2015-2020)

Figure 33. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Region (2015-2020)

Figure 34. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Region in 2019

Figure 35. North America Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 36. North America Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019

Figure 37. Canada Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 38. U.S. Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 39. Europe Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 40. Europe Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019

Figure 41. Germany America Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 42. France Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 43. U.K. Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 44. Italy Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 45. Russia Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 46. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 47. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Market Share by Regions in 2019

Figure 48. China Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 49. Japan Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 50. South Korea Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 51. Taiwan Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 52. Southeast Asia Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 53. India Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 54. Australia Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 55. Latin America Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 56. Latin America Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019

Figure 57. Mexico Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 58. Brazil Stereotactic-guided Biopsy Instrument Consumption Growth Rate (2015-2020) (K Units)

Figure 59. Production Market Share of Stereotactic-guided Biopsy Instrument by Type (2015-2020)

Figure 60. Production Market Share of Stereotactic-guided Biopsy Instrument by Type in 2019

Figure 61. Revenue Share of Stereotactic-guided Biopsy Instrument by Type (2015-2020)

Figure 62. Revenue Market Share of Stereotactic-guided Biopsy Instrument by Type in 2019

Figure 63. Global Stereotactic-guided Biopsy Instrument Production Growth by Type (2015-2020) (K Units)

Figure 64. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application (2015-2020)

Figure 65. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2019

Figure 66. Global Stereotactic-guided Biopsy Instrument Consumption Growth Rate by Application (2015-2020)

Figure 67. Price Trend of Key Raw Materials

Figure 68. Manufacturing Cost Structure of Stereotactic-guided Biopsy Instrument

Figure 69. Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument

Figure 70. Stereotactic-guided Biopsy Instrument Industrial Chain Analysis

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

Figure 73. Porter's Five Forces Analysis

Figure 74. Global Stereotactic-guided Biopsy Instrument Production Capacity (K Units) and Growth Rate Forecast (2021-2026)

Figure 75. Global Stereotactic-guided Biopsy Instrument Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 76. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 77. Global Stereotactic-guided Biopsy Instrument Price and Trend Forecast (2021-2026)

Figure 78. Global Stereotactic-guided Biopsy Instrument Production Market Share Forecast by Region (2021-2026)

Figure 79. North America Stereotactic-guided Biopsy Instrument Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 80. North America Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 81. Europe Stereotactic-guided Biopsy Instrument Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 82. Europe Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 83. China Stereotactic-guided Biopsy Instrument Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 84. China Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 85. Japan Stereotactic-guided Biopsy Instrument Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 86. Japan Stereotactic-guided Biopsy Instrument Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 87. Global Forecasted and Consumption Demand Analysis of Stereotactic-guided Biopsy Instrument

Figure 88. North America Stereotactic-guided Biopsy Instrument Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 89. Europe Stereotactic-guided Biopsy Instrument Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 90. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 91. Latin America Stereotactic-guided Biopsy Instrument Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 92. Global Stereotactic-guided Biopsy Instrument Production (K Units) Forecast by Type (2021-2026)

Figure 93. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Type (2021-2026)

Figure 94. Global Stereotactic-guided Biopsy Instrument Consumption Forecast by Application (2021-2026)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450